Cryo-cell International, Inc. (CCEL) Declares $0.90 Special Dividend; 17.3% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cord Blood Banking Leader Cryo-Cell Announces Special Cash Dividend
August 22, 2022 6:00 PM EDTOLDSMAR, Fla., Aug. 22, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (Cryo-Cell), the worlds first private cord blood bank to separate and store stem cells in 1992, announced today that its Board of Directors declares a one-time, special cash dividend of $0.90 per share of common stock to be paid to its shareholders of record as of the close of business on September 2, 2022.
Cryo-Cells Chairman of the Board and Co-CEO, David Portnoy, stated Cryo-Cells Board of Directors is pleased to reward its many long-time... More
